Saturday, July 11, 2026

pharma · Neoplasms,Non-Small Cell Lung Cancer

Tianjin Hemay Pharmaceutical

News and analysis for Tianjin Hemay Pharmaceutical on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
2
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Tianjin Hemay Pharmaceutical — regulatory, clinical, and market coverage.

News and analysis for Tianjin Hemay Pharmaceutical on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Tianjin Hemay Pharmaceutical yet.

Back to company overview →